SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

08 Aug 2025 Evaluate
The June 2025 quarter revenue stood at Rs. 137.27 millions, up 11.69% as compared to Rs. 122.90 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2025 is Rs. -2.71 millions as compared to Net Loss of Rs. -12.20 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to 5.02% as compared to -1.32% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 137.27 122.90 11.69 137.27 122.90 11.69 429.45 490.89 -12.52
Other Income 0.39 1.38 -71.74 0.39 1.38 -71.74 109.24 11.52 848.26
PBIDT 5.02 -1.32 -480.30 5.02 -1.32 -480.30 87.15 -26.09 -434.04
Interest 1.02 3.89 -73.78 1.02 3.89 -73.78 9.40 16.34 -42.47
PBDT 4.00 -5.21 -176.78 4.00 -5.21 -176.78 77.75 -42.43 -283.24
Depreciation 6.99 7.15 -2.24 6.99 7.15 -2.24 28.46 27.15 4.83
PBT -2.99 -12.36 -75.81 -2.99 -12.36 -75.81 49.29 -69.58 -170.84
TAX -0.28 -0.16 75.00 -0.28 -0.16 75.00 2.87 -0.06 -4883.33
Deferred Tax -0.28 -0.16 75.00 -0.28 -0.16 75.00 2.88 -0.04 -7300.00
PAT -2.71 -12.20 -77.79 -2.71 -12.20 -77.79 46.42 -69.52 -166.77
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 59.00 0.00
PBIDTM(%) 3.66 -1.07 -440.50 3.66 -1.07 -440.50 20.29 -5.31 -481.83

Makers Laboratories Share Price

160.15 2.40 (1.52%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×